FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
CNBC - 2024-04-26T11:02:36.000Z

The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.

In related news

8-year-old boy first in NY to receive FDA-approved gene therapy for rare inherited blood disorder
8-year-old Yusuf is making history as the first patient in the state of New York to undergo an FDA-approved gene therapy for a rare inherited blood disorder called beta-thalassemia.
- Related Articles
- In News
- From ABC7 New York
- 2024-04-18T20:55:00.000Z
Therapy dogs comfort Springfield’s first responders
For the individual behind every first responder’s badge, there is a physical and emotional toll from a job where traumatic events can be a daily occurrence.
- Related Articles
- In News
- From WWLP.com
- 2024-04-23T22:28:22.000Z
Ohio first in U.S. to screen newborns for rare condition
Ohio Governor Mike DeWine announced Monday that Ohio will become the first state in the nation to begin screening newborns for Duchenne Muscular Dystrophy (DMD).
- Related Articles
- In News
- From WKBN.com
- 2024-04-22T17:50:44.000Z